Showing results (1-10 of 1,881) with videos related to
Sort By:
Pageof 189
Nucleosides, Nucleotides & Nucleic Acids|June 15, 2010
How should thiopurine treatment be monitored?--methodological aspectsS Vikingsson, B Carlsson, S Almer, et al.Nucleosides, Nucleotides & Nucleic Acids|October 27, 2006
No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel diseaseM Lindqvist, U Hindorf, S Almer, et al.Nucleosides, Nucleotides & Nucleic Acids|June 15, 2010
Novel strategies in the thiopurine treatment of inflammatory bowel diseaseS AlmerGut|March 18, 2006
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel diseaseU Hindorf, M Lindqvist, C Peterson, et al.Journal of Chromatography. A|March 7, 2008
Retention of opioids and their glucuronides on a combined zwitterion and hydrophilic interaction stationary phaseS Vikingsson, R Kronstrand, M JosefssonEuropean Journal of Nuclear Medicine|September 1, 1995
Upregulation of granulocyte CD11b (CR 3) after labelling with technetium-99m hexamethylpropylene amine oximeS Almer, O LjunghusenLakartidningen|April 9, 1998
[Leukocyte scintigraphy, endoscopy, airway x-ray. New methods for the diagnosis of colitis and Crohn disease]S Almer, K SmedhEuropean Journal of Gastroenterology & Hepatology|October 19, 1999
The network: a strategy to describe the relationship between quality of life and disease activity. The case of inflammatory bowel diseaseH Hjortswang, S Almer, M StrömGastroenterologie Clinique Et Biologique|January 1, 1992
Retrograde distribution of a new 5-aminosalicylic acid enema in patients with ulcerative colitisS Almer, S Ekberg, M StrömThe American Journal of Gastroenterology|November 20, 1998
Health-related quality of life in Swedish patients with ulcerative colitisH Hjortswang, M Ström, S AlmerPageof 189